ipilimumab,acalabrutinib
astrazeneca,bms
[' aca ', 'lymsm', 'lymphoma', 'dlbcl', ' ipi ']
alduaij on cns relapse risk in hgbl-dh (myc/bcl2) - 2 year cns rate 6% - cns ipi 4-6 higher - no diff in relapse by cns ppx #ash22 #lymsm great presentation and answering of questions! 
Haematologist, Sir Charles Gairdner & Hollywood Private Hospitals
Professor, University of Western Australia
Founder/Director, Blood Cancer Research WA #lymSM